PathAI Overview

PathAI is a leading AI-powered pathology platform committed to improving patient outcomes through advanced technology and strategic collaborations. It delivers invaluable insights for biomarker discovery and drug development, while simultaneously streamlining laboratory workflows for both biopharma companies and pathology laboratories.

PathAI Key Features

Advanced Digital Pathology Platform: Features AISight, a cloud-native, intelligent enterprise workflow solution that acts as a central hub for case and image management, powering digital pathology workflows with integrated AI applications.
FDA-Cleared Diagnostic Solution: Includes AISight Dx, an FDA 510(k) cleared digital pathology platform specifically designed for primary diagnosis, ensuring high reliability and regulatory compliance.
Specialized AI Pathology Algorithms: Leverages a comprehensive suite of AI algorithms such as ArtifactDetect for automated slide quality analysis, TumorDetect for automated tumor assessment and prioritization, and AIM-Tumor Cellularity for precise AI-based cellularity assessments.
Biopharma Drug & Diagnostic Development: Supports all phases of drug and diagnostic development, from translational research and real-world data analysis to clinical trials and companion diagnostics, providing AI-enabled insights.
Centralized Lab Operations: Offers solutions for central pathology laboratory operations, enhancing efficiency and standardization for research and clinical development efforts.
Collaborative Network Access: Provides access to a Precision Pathology Network and integrates with partner algorithm products like Deep Bio and Paige, expanding its capabilities and reach.